mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.08 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.08 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.09 |